EUVIMEDEUVIMED entdecken
Crossref

Medication persistence among patients with asthma/COPD drugs

Dan Haupt, Kristin Krigsman, J Lars G Nilsson

Pharmacy World & Science · 2008-10 · 30 (5) · 509-514

DOI: 10.1007/s11096-008-9197-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy World & Science, online erschienen am 05.02.2008. Verfasst von Dan Haupt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences, Luleå Tecnical University, 971 87 Lulea, Sweden. Hauptthemen laut MEDLINE: Drug Monitoring. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To determine medication possession ratio (MPR) of patients with asthma/COPD drugs. METHOD: Individual patient's volumes of asthma/COPD drugs (ATC-code R03) for 2000-2004 were obtained from a pharmacy record database. For each patient the MPR was calculated as the percentage of the treatment time that the patient had drugs available. MAIN OUTCOME MEASURE: Medication possession ratio (MPR). RESULTS: A total of 1,812 patients, 20 years and older, with dispensed asthma/COPD drugs were registered in the database, 928 patients (51%) had acquired drugs less than once per year (68% for 20-29 years old) during the 5-year study. Only 13% of the patients had steroids and steroid combinations available to allow continuous treatment. Eight percent of the patients 20-29 years old had MPR > or = 80% of all the included drugs and 5% when only steroids and steroid combinations were considered. About 25% of the patients had acquired 80% of the total volume of asthma/COPD drugs. CONCLUSION: The majority of the patients, and particularly those in the youngest age group used asthma/COPD drugs only sporadically. This may indicate undermedication which is likely to have a negative impact on patient outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringAdultAge FactorsAgedAged, 80 and overAnti-Asthmatic AgentsAsthmaDatabases, FactualFemaleGlucocorticoidsHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveSwedenTreatment OutcomeYoung Adult

Substanzen

Anti-Asthmatic AgentsGlucocorticoids

Autor:innen und Institutionen

  • Health Sciences, Luleå Tecnical University, 971 87 Lulea, Sweden.

Zitieren

APA

Haupt, D., Krigsman, K., & Nilsson, J. L. (2008). Medication persistence among patients with asthma/COPD drugs. Pharmacy World & Science, 30(5), 509-514. https://doi.org/10.1007/s11096-008-9197-4

Vancouver

Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/COPD drugs. Pharmacy World & Science. 2008;30(5):509-514. doi:10.1007/s11096-008-9197-4

BibTeX
@article{Haupt2008,
  author = {Haupt, Dan and Krigsman, Kristin and Nilsson, J Lars G},
  title = {Medication persistence among patients with asthma/COPD drugs},
  journal = {Pharmacy World & Science},
  year = {2008},
  volume = {30},
  number = {5},
  pages = {509--514},
  doi = {10.1007/s11096-008-9197-4}
}
Kostenlos starten →